Application of CT combined with serum tumor markers in identification of borderline ovarian tumors and benign epithelial ovarian tumors
10.3969/j.issn.1671-8348.2017.25.014
- VernacularTitle:CT联合血清肿瘤标记物在鉴别卵巢交界性肿瘤和良性上皮性肿瘤中的应用
- Author:
Xinlin SHI
;
Wei ZHANG
;
Dajing GUO
;
Ting CHEN
;
Dong SUN
;
Rui PENG
- Keywords:
ovarian neoplasms;
tomography,X-ray computed;
biomarkers,tumor
- From:
Chongqing Medicine
2017;46(25):3496-3499
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the differential diagnostic value of computed tomography (CT) combined with serum tumor markers in borderline ovarian tumors (BOT) and benign epithelial ovarian tumors (BET).Methods The CT data in 28 patients with BOT and 41 patients with BET,both confirmed by surgery and pathological,were analyzed retrospectively.Their preoperative serum carbohydrate antigen 125 (CA125),human epididymis secretory protein 4 (HE4) and carcinoembryonic antigen (CEA) detection results were collected.The CT images features and serum tumor markers levels were compared between the two groups.Results The difference in the appearance rate of tumor solid composition,thick septum and wall nodule between the two groups had statistical significance (x2 =25.135,5.240,5.066,P＜0.05).The serum CA125 level had statistical difference between the two groups (Z=3.202,P＜0.05),while serum HE4 and CEA levels had no statistically significant difference between the two groups(Z=0.330,1.122,P＞0.05).The optimal critical value,sensitivity and specificity of serum CA125 level in differential diagnosis of two kinds of tumor was 42.45 U/mL,53.6％ and 85.4％.The overall diagnostic rate of solid composition and thick septum for diagnosing the two kinds of tumor was 78.5 ％.The overall diagnostic rate of solid composition,thick septum and CA125 level for diagnosing the two kinds of tumor was 81.2％.Conclusion The appearance of solid composition,thick septum and serum CA125 level increase in epithelial ovarian tumor may help to identify BOT and BET.
